Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial
The adult stem cell company Osiris Therapeutics accomplishes an historic milestone by completing patient enrollment in the first phase III clinical trial ever to be conducted with adult stem cells in the treatment of Graft versus Host Disease.